Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

S-1 demonstrates excellent antitumor activity in phase II

March 9, 1998

Lilly antifolate evaluated in phase II

March 9, 1998

Favorable phase I results obtained with G-3139 in NHL

March 9, 1998

Pharmacia & Upjohn presents new tyrosine kinase inhibitors

March 6, 1998

Antitumor agents isolated from fungal strains by Roche

March 6, 1998

PKC antisense oligonucleotide shows promise in cancer therapy

March 6, 1998

Purdue discloses antitumor selenophene compounds

March 5, 1998

Colchicine analogues from Indena show potential for resistant tumors

March 5, 1998

Chemopotentiating agents in R&D at Nippon Flour Milling

March 5, 1998

Gliadel Wafer approved for marketing in Brazil

March 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...